Clin Oncol | Volume 2, Issue 1 | Review Article | Open Access

Addressing the Challenges of HIV/AIDS-Defining Non- Hodgkin’s Lymphomas in Sub-Saharan Africa

Shaheen Mowla*

Department of Pathology, Faculty of Health Sciences, University of Cape Town, South Africa

*Correspondance to: Shaheen Mowla 

Fulltext PDF


Southern Africa has the highest HIV incidence worldwide. Thus far there is no cure; however, the lives of individuals infected with the virus can be prolonged through the use of Highly Active AntiRetroviral Therapy (HAART). According to the United Nations Programme on HIV and AIDS (UNAIDS) fact sheet for 2015, 2 out of 3 new HIV infections are in the Sub-Saharan African region, with approximately 25.8 million people living with HIV and 1.4 million new infections in 2014. In 2004, South Africa introduced ART (Anti-retroviral Therapy) free of charge in the public healthcare sector, and today South Africa has the largest treatment programme in the world - approximately 2.4 million people have received the life-saving treatment which has significantly increased their life expectancy.


Mowla S. Addressing the Challenges of HIV/AIDS-Defining Non-Hodgkin’s Lymphomas in Sub-Saharan Africa. Clin Oncol. 2017; 2: 1366.

Subscribe to Our Newsletter